Answers are grounded in this paper and cite their sources.
Analysis demonstrates FDA approvals for pediatric oncology, indicating success of collaboration in evidence production.
Almost half of FDA approved pediatric indications for oncology therapeutics were supported by data from COG trials, highlighting the effectiveness of this public-private partnership model in producing the level of clinical evidence required for regulatory success.
No takes yet. Share an insight, caveat, or question.
Macy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: